Total Funding
90
72
Total FundingFunding Round raised
Growth Score 90 in past quarter
-5 pts
Heat Score 72 in past quarter
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
35705
Cartherics creates immunotherapy treatments to combat cancers.
- Peter J. Hudson: Co-founder and Sr. Scientific Advisor
- Walid Azar: Chief Translational OfficerPast Role: CSL, Research Scientist
About the Company
Cartherics develops immunotherapy therapies to treat various malignancies. They combine immune targeting with gene editing and CAR technology to develop cell therapy and provide patients with a wider range of over-the-counter medications.